Funding

Graph Therapeutics

Austria · Biotech · AI

Develops precision medicines for inflammatory and immune-mediated diseases using AI-powered patient cell analysis

Visit graphtx.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series A$5MAustrian Research Promotion Agency (FFG) — Role not disclosedAustria Wirtschaftsservice (AWS) — Role not disclosedDaphni — Role not disclosedMerantix Capital — Role not disclosedNAVEC Investment Management — Role not disclosedSquareOne — Role not disclosed

Investors

Austrian Research Promotion Agency (FFG)Series AAustria Wirtschaftsservice (AWS)Series ADaphniSeries AMerantix CapitalSeries ANAVEC Investment ManagementSeries ASquareOneSeries A

Coverage

Jun 22, 2026Graph Therapeutics · Series A

Similar companies

Fairy DevicesTokyo company developing wearable devices and remote-assistance software for industrial field workers.Undisclosed · JICN equity investment
Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Knowledge WorkTokyo software company developing sales AI agents, an agent operating platform and consulting services for enterprise sales teams.¥4.8B · Series C debt second close
Sourcesgraphtx.com ↗